Neumora Therapeutics announced the appointment of Jason Duncan as chief legal officer. Mr. Duncan will be a member of Neumora’s Executive Team, reporting to Henry Gosebruch, CEO, and will oversee all aspects of the Company’s legal and compliance functions. Prior to joining Neumora, he served as chief legal officer, general counsel, secretary to the board of directors and head of program management at Albireo Pharma.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NMRA:
- Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
- After AbbVie agrees to buy Cerevel, analysts weigh in on who may be next
- Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study
- Neumora Therapeutics announces NMRA-266 IND clearance, initiation Phase 1 study
- Three new option listings and three option delistings on November 7th